Borowicz, D.M.; Shipulin, K.N.; Mytsin, G.V.; Skrobała, A.; Milecki, P.; Gayevsky, V.N.; Vondráček, V.; Malicki, J.
Ultra-Hypofractionated Proton Therapy in Localized Prostate Cancer: Passive Scattering versus Intensity-Modulated Proton Therapy. J. Pers. Med. 2021, 11, 1311.
https://doi.org/10.3390/jpm11121311
AMA Style
Borowicz DM, Shipulin KN, Mytsin GV, Skrobała A, Milecki P, Gayevsky VN, Vondráček V, Malicki J.
Ultra-Hypofractionated Proton Therapy in Localized Prostate Cancer: Passive Scattering versus Intensity-Modulated Proton Therapy. Journal of Personalized Medicine. 2021; 11(12):1311.
https://doi.org/10.3390/jpm11121311
Chicago/Turabian Style
Borowicz, Dorota Maria, Konstantin N. Shipulin, Gennady V. Mytsin, Agnieszka Skrobała, Piotr Milecki, Victor N. Gayevsky, Vladimir Vondráček, and Julian Malicki.
2021. "Ultra-Hypofractionated Proton Therapy in Localized Prostate Cancer: Passive Scattering versus Intensity-Modulated Proton Therapy" Journal of Personalized Medicine 11, no. 12: 1311.
https://doi.org/10.3390/jpm11121311
APA Style
Borowicz, D. M., Shipulin, K. N., Mytsin, G. V., Skrobała, A., Milecki, P., Gayevsky, V. N., Vondráček, V., & Malicki, J.
(2021). Ultra-Hypofractionated Proton Therapy in Localized Prostate Cancer: Passive Scattering versus Intensity-Modulated Proton Therapy. Journal of Personalized Medicine, 11(12), 1311.
https://doi.org/10.3390/jpm11121311